Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.

This study describes the effects of bezafibrate, an analogue of clofibrate, on the plasma lipid and lipoprotein profiles of 11 hypertriglyceridemic subjects and on their metabolism of apolipoproteins A-I, A-II, and B. The major action of the drug was to lower plasma triglyceride (by 58%; P less than...

Descrición completa

Detalles Bibliográficos

Publicado en:	J Clin Invest
Principais autores:	Shepherd, J, Packard, C J, Stewart, J M, Atmeh, R F, Clark, R S, Boag, D E, Carr, K, Lorimer, A R, Ballantyne, D, Morgan, H G
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Clinical Investigation 1984
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC425409/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6511921/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI111643
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!